SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001260872-04-000011
Filing Date
2004-01-29
Accepted
2004-01-29 19:15:06
Documents
1
Period of Report
2003-04-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4/A  
1 PRIMARY DOCUMENT edgardoc.xml 4/A 3922
  Complete submission text file 0001260872-04-000011.txt   5708
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Issuer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4440 143RD PL N E BELLEVUE WA 98007
Business Address 4440 143RD PL N E BELLEVUE WA 98007
GLAVIN JAMES B (Reporting) CIK: 0001048640 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-18006 | Film No.: 04553851